Noninvasive patient monitoring and pulse oximetry for hospitals and clinical settings
Masimo manufactures medical monitoring hardware and sensors for hospital and clinical use, with a tech stack spanning embedded systems (C++, Python, MATLAB), medical data standards (HL7, FHIR, DICOM), and ML frameworks (TensorFlow, PyTorch). The hiring mix is sales-heavy relative to engineering, and active projects center on new product launches, manufacturing optimization, and expanding end-user adoption—signaling a push to grow installed base while tightening operational margins. Pain points cluster around inventory management, manufacturing efficiency, and sales conversion.
Notable leadership hires: Sales Director
Masimo is a public medical technology company founded in 1989, headquartered in Irvine, CA, with 1,001–5,000 employees. The company develops noninvasive monitoring technologies, sensors, and patient monitors, with a focus on pulse oximetry and clinical automation. Masimo SET pulse oximetry is used on an estimated 200+ million patients annually and is the primary pulse oximetry at all top 10 U.S. hospitals by recent rankings. The product portfolio spans monitoring hardware, connectivity solutions, and clinical workflow automation. The company operates a global manufacturing footprint and maintains sales and support teams across 20+ countries.
Masimo's stack includes embedded languages (C++, C, Python, MATLAB), medical data standards (HL7, FHIR, DICOM), ML frameworks (TensorFlow, PyTorch), hardware design tools (CAD, Altium Designer), and real-time visualization (Qt, OpenGL ES). PostgreSQL and MySQL handle data persistence.
Key pain points include inventory management and cost reduction, manufacturing process improvement and downtime reduction, sales conversion and account growth, forecast accuracy, and managing product lifecycle transitions during new launches.
Other companies in the same industry, closest in size